Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -604.20% is 11% above its 4-year average of -677.32%, near the high end of its 4-year range (-4338.31%–-83.14%).
As of the fiscal period ended Tuesday, June 30, 2026. 76.07% below its 12-month average of -343.17%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -604.20%.
RETURN ON INVESTED CAPITAL (ROIC)
-604.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-343.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-1142.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-76.07%
CURRENT VS 3Y AVG
+47.10%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-1595.04%
vs the sector median at left
MiNK Therapeutics, Inc.
Market Cap
$58.94M
Return on Invested Capital (ROIC)
-604.20%
TTM Avg
-343.17%
3Y Avg
-1142.20%
5Y Avg
N/A
Market Cap
$59.41M
Return on Invested Capital (ROIC)
-79.68%
TTM Avg
-67.52%
3Y Avg
-59.81%
5Y Avg
-47.97%
Market Cap
$58.85M
Return on Invested Capital (ROIC)
-26.13%
TTM Avg
-90.47%
3Y Avg
-104.07%
5Y Avg
-130.48%
Market Cap
$59.76M
Return on Invested Capital (ROIC)
-1235.48%
TTM Avg
-801.38%
3Y Avg
-433.95%
5Y Avg
-312.84%
Market Cap
$58.59M
Return on Invested Capital (ROIC)
-136.77%
TTM Avg
-80.48%
3Y Avg
-75.99%
5Y Avg
-77.22%
Market Cap
$58.43M
Return on Invested Capital (ROIC)
-43.97%
TTM Avg
-40.46%
3Y Avg
-48.41%
5Y Avg
-43.33%
Market Cap
$61.87M
Return on Invested Capital (ROIC)
-129.67%
TTM Avg
-97.71%
3Y Avg
-90.63%
5Y Avg
-82.49%
Market Cap
$58.16M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$61.55M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.94M | -604.20% | -343.17% | -1142.20% | N/A |
| Adicet Bio, Inc. (ACET)vs › | $59.41M | -79.68% | -67.52% | -59.81% | -47.97% |
| Xilio Therapeutics, Inc. (XLO)vs › | $58.85M | -26.13% | -90.47% | -104.07% | -130.48% |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.76M | -1235.48% | -801.38% | -433.95% | -312.84% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $58.59M | -136.77% | -80.48% | -75.99% | -77.22% |
| Boundless Bio, Inc. (BOLD)vs › | $58.43M | -43.97% | -40.46% | -48.41% | -43.33% |
| Fractyl Health, Inc. (GUTS)vs › | $61.87M | -129.67% | -97.71% | -90.63% | -82.49% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.16M | -3699.99% | -104.88% | -89.50% | -74.29% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.55M | -52.40% | -44.92% | -44.92% | -44.02% |
| Talphera, Inc. (TLPH)vs › | $57.09M | -65.20% | -74.94% | -77.07% | -67.70% |
ROIC
-604.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -604.20% |
| 2026-03-31 | -415.48% |
| 2025-12-31 | -195.52% |
| 2025-09-30 | -157.48% |
| 2023-06-30 | -4338.31% |
| 2023-03-31 | -551.23% |
| 2022-12-31 | -352.16% |
| 2022-09-30 | -431.04% |
| 2022-06-30 | -186.52% |
| 2022-03-31 | -135.48% |
| 2021-12-31 | -83.14% |
